CT26-hNECTIN4

Export PDF

Strain Information

Cell Line

CT26-Tg(hNECTIN4)Smoc

Cat. NO.

NM-S24A-TM44

Model Description

Nectin4 gene humanized CT26 cell line

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Fig1. NECTIN4 expression expression in CT26-hNECTIN4 cell lines.

image.png

Fig2. In vivo validation of CT26-hNECTIN4 in BALB/c mice. 

BALB/c mice were inoculated with CT26-hNECTIN4 subcutaneously at 3×106 cells/mouse inoculum for tumor development.

image.png

Fig3. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.

image.png

Fig4. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more